Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zivanovic

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
Cancers|January 8, 2025
Evaluation of Ex Vivo Shear Wave Elastography of Axillary Sentinel Lymph Nodes in Patients with Early Breast CancerRiku Togawa, Helena Dahm, Manuel Feisst, et al.
Gynecologic Oncology|May 28, 2021
Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysisBeryl L Manning-Geist, Dennis S Chi, Kara Long Roche, et al.
Gynecologic Oncology Reports|September 6, 2021
Quaternary and beyond cytoreduction: An updated and expanded analysisBeryl L Manning-Geist, Dennis S Chi, Kara Long Roche, et al.
Annals of Surgical Oncology|May 22, 2015
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node MappingMaria B Schiavone, Oliver Zivanovic, Qin Zhou, et al.
Gynecologic Oncology|September 9, 2008
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapyOliver Zivanovic, Kaled M Alektiar, Yukio Sonoda, et al.
Gynecologic Oncology|September 16, 2011
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)Dennis S Chi, Fernanda Musa, Fanny Dao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 10, 2015
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancerRudy S Suidan, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|April 28, 2009
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigmDennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, et al.
Gynecologic Oncology|September 1, 2014
Prognostic significance of tumor-associated macrophages in endometrial adenocarcinomaKirsten Kübler, Tiyasha H Ayub, Sarah K Weber, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancerTao Dao, Martin G Klatt, Tatyana Korontsvit, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
Cancers|January 8, 2025
Evaluation of Ex Vivo Shear Wave Elastography of Axillary Sentinel Lymph Nodes in Patients with Early Breast CancerRiku Togawa, Helena Dahm, Manuel Feisst, et al.
Gynecologic Oncology|May 28, 2021
Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysisBeryl L Manning-Geist, Dennis S Chi, Kara Long Roche, et al.
Gynecologic Oncology Reports|September 6, 2021
Quaternary and beyond cytoreduction: An updated and expanded analysisBeryl L Manning-Geist, Dennis S Chi, Kara Long Roche, et al.
Annals of Surgical Oncology|May 22, 2015
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node MappingMaria B Schiavone, Oliver Zivanovic, Qin Zhou, et al.
Gynecologic Oncology|September 9, 2008
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapyOliver Zivanovic, Kaled M Alektiar, Yukio Sonoda, et al.
Gynecologic Oncology|September 16, 2011
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)Dennis S Chi, Fernanda Musa, Fanny Dao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 10, 2015
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancerRudy S Suidan, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|April 28, 2009
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigmDennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, et al.
Gynecologic Oncology|September 1, 2014
Prognostic significance of tumor-associated macrophages in endometrial adenocarcinomaKirsten Kübler, Tiyasha H Ayub, Sarah K Weber, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancerTao Dao, Martin G Klatt, Tatyana Korontsvit, et al.
Pageof 21